5 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Lead-212 PSV359 Therapy for Patients With Solid TumorsAdnexal Diseases, Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, Urogenital Diseases, Urogenital Neoplasms, adenoma, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, epithelial neoplasm, esophageal cancer, esophageal disorder, female reproductive system disorder, female reproductive system neoplasm, gastric cancer, gastric neoplasm, gonadal disorder, head and neck cancer, intestinal disorder, malignant endocrine neoplasm, mesothelial neoplasm, mesothelioma, neoplasm, ovarian cancer, ovarian disorder, pancreatic ductal adenocarcinoma, rectal disorder, sarcoma, stomach disorderRecruitingPhase 1 / Phase 22026-10-07NCT06710756
MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced MelanomaNeoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, metastatic melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasmRecruitingPhase 1 / Phase 22026-06-10NCT05655312
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive TumorsNeoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, central nervous system cancer, digestive system neuroendocrine neoplasm, meningioma, neoplasm, nervous system disorder, neuroendocrine neoplasm, paraganglioma, pheochromocytoma, primitive neuroectodermal tumor, tumor of meninges, vascular cancerRecruitingPhase 1 / Phase 22026-05-14NCT05636618
A Safety Study of 212Pb-VMT-alpha-NET in Patients With Neuroendocrine TumorsAdenoma, Islet Cell, Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, adenoma, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, neoplasm, neuroendocrine neoplasm, pancreas disorder, pancreatic neoplasm, primitive neuroectodermal tumorActive, not recruitingEarly phase 12025-11-04NCT06148636
A First-in-human Clinical Trial to Evaluate an Alpha-radiation Imaging AgentNeuroendocrine Tumor Grade 1; Neuroendocrine Tumor Grade 2Active, not recruitingEarly phase 12025-07-14NCT05111509